Overview
- CMS proposed disqualifying hospitals from Medicare and Medicaid if they provide puberty blockers or surgeries to people under 18.
- The FDA issued warning letters to 12 manufacturers and sellers of chest binders marketed to children and cautioned that noncompliance could lead to product seizures.
- NIH Director Jay Bhattacharya said the agency will stop supporting research on gender transition in minors.
- HHS declared that current evidence does not show puberty blockers, cross-sex hormones or surgeries are safe and effective for youths, citing its review and reports from other countries.
- Major medical associations and LGBTQ+ advocates criticized the actions as harmful to access, the ACLU signaled court challenges, and several measures still require formal rulemaking on top of existing bans in 27 states.